Rapid diagnosis of glucocorticoid suppressible hyperaldosteronism in infants and adolescents.
Where this comes from
- Record sourced from PubMed, PMID 7915100.
- Also identified by PMC identifier 1029910.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Glucocorticoid suppressible hyperaldosteronism (GSH) is an uncommon form of dominantly inherited hypertension. Presentation with hypertension and complications such as stroke in early life are well recognised. The use of a simple genetic test carried out on blood or placenta facilitates the detection of infants and children with GSH before the development of hypertension, allowing prompt treatment of hypertension if it occurs, and an opportunity to study the effects of growth and environmental influences on the progression of the condition.
Medical subject headings
- Glucocorticoids
- Hyperaldosteronism